BlackRock Institutional Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$50.6M	Buy	798,238 +38,208	+5%	+$2.41M	0.01%	1345
2016 Q3	$48.4M	Sell	760,030 -40,367	-5%	-$2.96M	0.01%	1322
2016 Q2	$59.6M	Buy	800,397 +41,306	+5%	+$3.07M	0.01%	1131
2016 Q1	$50.7M	Buy	759,091 +165	+0%	+$10K	0.01%	1209
2015 Q4	$51.3M	Sell	758,926 -2,004	-0.3%	-$124K	0.01%	1226
2015 Q3	$40.7M	Sell	760,930 -68,369	-8%	-$4.15M	0.01%	1352
2015 Q2	$52.2M	Sell	829,299 -86,165	-9%	-$4.7M	0.01%	1271
2015 Q1	$44M	Sell	915,464 -15,337	-2%	-$588K	0.01%	1396
2014 Q4	$30.9M	Buy	930,801 +54,205	+6%	+$1.76M	﹤0.01%	1623
2014 Q3	$25.7M	Sell	876,596 -74,126	-8%	-$2.46M	﹤0.01%	1725
2014 Q2	$36.9M	Buy	950,722 +34,951	+4%	+$1.42M	0.01%	1536
2014 Q1	$38.4M	Buy	915,771 +37,151	+4%	+$1.55M	0.01%	1489
2013 Q4	$28.8M	Sell	878,620 -38,847	-4%	-$1.27M	0.01%	1666
2013 Q3	$24.8M	Sell	917,467 -159,547	-15%	-$4.49M	﹤0.01%	1701
2013 Q2	$25.1M	Buy	+1,077,014	New	+$19.4M	0.01%	1630